Avost Plus Eye Drop
Avost Plus Eye Drop is manufactured by Ibn-Sina Pharmaceuticals Ltd. Avost Plus Eye Drop contains 0.004%+0.5% Travoprost + Timolol Maleate. It is Drugs for miotics and glaucoma class drug.
Travoprost and Timolol reduce intraocular pressure (IOP) by complementary mechanisms of action. Travoprost is a prostaglandin analogue which reduces IOP by increasing trabecular outflow & uveoscleral outflow. Timolol is a non-selective beta adrenergic receptor blocker that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anesthetic (membrane stabilizing) activity. It lowers IOP by decreasing the formation of aqueous humor in the ciliary epithelium.
This Sterile Ophthalmic Solution is used for the treatment of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension who are insufficiently responsive to single therapy with prostaglandin analogue or topical beta blocker.
|Brand Name:||Avost Plus|
|Generic:||Travoprost + Timolol Maleate|
|Therapeutic Class:||Drugs for miotics and glaucoma|
|Manufacturer:||Ibn-Sina Pharmaceuticals Ltd|
|Last Updated:||November 22, 2020 at 6:15 pm|
Table Of contents
Avost Plus contains Travoprost + Timolol Maleate 0.004%+0.5%. Avost Plus Dosage:
Instill one drop in the conjunctival sac of the affected eye(s) once daily at about the same time each day, preferably in the evening.
No serious adverse reactions are reported. Most frequently reported side effects are ocular hyperemia.
For ophthalmic use only. Patients should remove their contact lenses prior to instilling this preparation and should not insert their lenses until 15 minutes after instillation of the preparation.
Pregnancy Lactation use
Use in pregnancy: There are no adequate and well-controlled studies in pregnant women. It should not be used during pregnancy.
Use in lactation: Caution should be exercised when Avost Plus is administered to a nursing mother.
Contraindicated in patients who are hypersensitive to Travoprost, Timolol or any of the components of this preparation.
Use in children: Safety and effectiveness in pediatric patients have not been established.
Use in elderly patients: No overall differences in safety and effectiveness have been observed between elderly and other adult patients.
Interaction with other Medicine
Store in a cool, dry place, away from heat and direct light. Keep out of the reach of children. Do not use more than 4 weeks after opening the bottle